NCT00988585View on ClinicalTrials.gov

Evaluation of the Safety and Biologic Effects of an Eicosapentaenoic (EPA)-Enriched Oil

PHASE1CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

April 30, 2009

Primary Completion Date

December 31, 2009

Study Completion Date

December 31, 2009

Conditions
Heart Disease
Interventions
DIETARY_SUPPLEMENT

EPA 600

EPA 600 mg/day for 6 weeks

DIETARY_SUPPLEMENT

EPA 1800

1800 mg/day for 6 weeks

DIETARY_SUPPLEMENT

Olive Oil

600 mg/day for 6 weeks

DIETARY_SUPPLEMENT

DHA

600 mg/day for 6 weeks

Trial Locations (1)

02111

Cardiovascular Research Associates, Boston

Sponsors
All Listed Sponsors
collaborator

Dupont Applied Biosciences

INDUSTRY

lead

Cardiovascular Research Associates

NETWORK